Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments
Company
Lexeo Therapeutics
New York CityBiotechnologyHealth CareGeneticsTherapeuticsDescription
Lexeo Therapeutics, Inc. announces new executive appointments to lead the evolution of the company’s pipeline into late-stage clinical development.
Quick answer
Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments (February 5, 2024). Lexeo Therapeutics is based in New York City, New York, United States.
- What did Lexeo Therapeutics announce on February 5, 2024?
- Lexeo Therapeutics, Inc. announces new executive appointments to lead the evolution of the company’s pipeline into late-stage clinical development.
- What does Lexeo Therapeutics do?
- Lexeo Therapeutics is a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated.
- Where is Lexeo Therapeutics based?
- Lexeo Therapeutics is based in New York City, New York, United States.
- Which similar companies made leadership changes around the same time?
- Precision BioSciences (February 13, 2024), Elevation Oncology (March 4, 2024), Prime Medicine (January 5, 2024) and BioMarin Pharmaceutical (March 7, 2024) also announced leadership changes within 45 days of Lexeo Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Genetics and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Precision BioSciences Promotes Naresh Tanna to Vice President of Investor Relations (February 13, 2024)
- Elevation Oncology Appoints Julie Cherrington as Chief Executive Officer and Alan Sandler as Chief Medical Officer (March 4, 2024)
- Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer (January 5, 2024)
- BioMarin Names Cristin Hubbard as Executive Vice President and Chief Commercial Officer (March 7, 2024)
- VolitionRx Limited Appoints Dr Andrew Retter as Chief Medical Officer (March 19, 2024)
- Corvus Pharmaceuticals Appoints Jeffrey Arcara as Chief Business Officer (February 6, 2024)
Who to call at Lexeo Therapeutics, and when
A new leader at Lexeo Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Lexeo Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lexeo Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lexeo Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lexeo Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Lexeo Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.